CCR5 antibodies HGS004 and HGS101 preferentially inhibit drug-bound CCR5 infection and restore drug sensitivity of Maraviroc-resistant HIV-1 in primary cells

Por Latinovic, Olga, Reitz, Marvin, Le, Nhut M., Foulke, James S., Fätkenheuer, Gerd, Lehmann, Clara, Redfield, Robert R., Heredia, Alonso
Publicado em 2011

Indirubin 3′-Monoxime, from a Chinese Traditional Herbal Formula, Suppresses Viremia in Humanized Mice Infected with Multidrug-Resistant HIV

Por Heredia, Alonso, Natesan, Senthilkumar, Le, Nhut M., Medina-Moreno, Sandra, Zapata, Juan C., Reitz, Marvin, Bryant, Joseph, Redfield, Robert R.
Publicado em 2014

Targeting of the Purine Biosynthesis Host Cell Pathway Enhances the Activity of Tenofovir Against Sensitive and Drug-Resistant HIV-1

Por Heredia, Alonso, Davis, Charles E., Reitz, Marvin S., Le, Nhut M., Wainberg, Mark A., Foulke, James S., Wang, Lai-Xi, Redfield, Robert R.
Publicado em 2013

Targeting of CDK9 with indirubin 3’-monoxime safely and durably reduces HIV viremia in chronically infected humanized mice

Por Medina-Moreno, Sandra, Dowling, Thomas C., Zapata, Juan C., Le, Nhut M., Sausville, Edward, Bryant, Joseph, Redfield, Robert R., Heredia, Alonso
Publicado no PLoS One (2017)

Targeting Host Nucleotide Biosynthesis with Resveratrol Inhibits Emtricitabine (FTC)-resistant HIV-1

Por Heredia, Alonso, Davis, Charles, Amin, Mohammed N, Le, Nhut M, Wainberg, Mark A, Oliveira, Maureen, Deeks, Steven G, Wang, Lai-Xi, Redfield, Robert R
Publicado no AIDS (2014)